SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001104659-24-029465
Filing Date
2024-02-29
Accepted
2024-02-29 17:26:11
Documents
5
Period of Report
2024-02-29

Document Format Files

Seq Description Document Type Size
1 PREM14A tm247409-1_prem14a.htm PREM14A 4301320
2 EX-FILING FEES tm247409d3_ex-filingfees.htm EX-FILING FEES 19053
3 GRAPHIC lg_inhibrx-pn.jpg GRAPHIC 15684
4 GRAPHIC px_24inhibprxy01pg01-4clr.jpg GRAPHIC 289108
5 GRAPHIC px_24inhibprxy01pg02-4c.jpg GRAPHIC 209887
  Complete submission text file 0001104659-24-029465.txt   4966158
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Filer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-39452 | Film No.: 24705274
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)